GLP-1RAs and GIP/GLP-1RAs prescribed to **23.4%** of elderly Japanese T2D patients, often with other caution-listed drugs.
Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report.
Abstract
GLP-1RAs and GIP/GLP-1RAs were prescribed to 23.4% of elderly Japanese Type 2 Diabetes patients, frequently alongside other glucose-lowering drugs requiring special caution.